fbpx

Medical Annuity Could Be Best Option for Investor With Cancer

Dear Mr. Berko: I have cancer, and the prognosis is not good.

I am 71 and might be able to live for another seven to eight years with proper care, which, as you know, is very costly. This cost is hard on my family and draining our income. I have $330,000 invested in the stock market (mostly blue chips), and the dividends earn me about $11,000 annually. My pension, Social Security and investments do not cover my expenses today. I need more income to live on, and my investments must be very safe. My stockbroker suggested a single premium immediate annuity that would give me $1,750 a month, or $21,000 a year, on an investment of $280,000. That would be just perfect. He would have me invest the remaining $50,000 in five high-yielding stocks (names enclosed) paying over 10 percent. I know there are much higher-paying stocks, but I don’t know which ones are good and safe. My daughter suggested I write you for recommendations because you would know some good, safe stocks paying 10 percent or more. Please answer as quickly as you can. We’re nervous and hanging in libido waiting for your answer. — PM, Buffalo, N.Y.

Dear PM: “Hanging in libido,” now that’s interesting.

There are good companies paying over 10 percent that I can recommend, but I can’t recommend any “good and safe” companies paying over 10 percent. Among the many dictums in this business is, “The higher the yield the higher the risk.” Of the five high yielders your broker recommends, four are neither good nor safe, so their prices and dividends will eventually fall. His New Residential Investment Corp. (NRZ-$16.30) recommendation, paying 12.4 percent, is the only one to keep. Then consider the real estate investment trust Ellington Residential Mortgage (EARN-$14.50), yielding 11.1 percent, Vistra Energy (VST-$17.25), yielding 13 percent, Telstra (TLSYY-$14), yielding 8 percent, and WhiteHorse Finance (WHF-$14.10), yielding 10 percent. These issues are much less unsafe than those he recommended. Still, they’re quite iffy.

And there’s a better annuity solution. It’s called a medically underwritten single premium immediate annuity, though your broker probably knows nothing of them because the commissions are embarrassingly lower than that of the typical SPIA. In exchange for handing over $280,000 for a medical annuity, you would be paid a much higher income than you would receive from the usual SPIA. A medical SPIA doesn’t have hidden fees. And in addition to the reasonable commission costs, the administration fees are low. A medical annuity is basically a straightforward, uncomplicated investment.

However, to qualify for a medical SPIA, you must have a chronic illness along the lines of advanced diabetes, lung cancer, HIV, Lou Gehrig’s disease, kidney failure, Parkinson’s disease or Hodgkin lymphoma. Though this sounds foreboding, a medical annuity can be a life-giver. A 71-year-old purchasing a regular $280,000 SPIA would receive between $1,700 and $1,800 a month, or between $20,400 and $21,600 annually, depending on the company issuing the policy. Yes, that’s a lot more than the $11,000 a year you’re getting from the dividends in your stock portfolio, but the payouts on a medical SPIA — because of your anticipated shorter life span — would be significantly more than those of the SPIA recommended by your broker. A $280,000 investment in a medical annuity could pay you between $2,100 and $2,600 a month.

There is a downside. If you pass away after purchasing a standard medical annuity, the payouts end immediately upon your death. You can structure this annuity to pay survivor benefits, but only if you’re willing to accept lower monthly payments. That said, the lower payments would still be higher than the payouts from a standard SPIA.

Mutual of Omaha, MetLife and Genworth Financial are among the very few companies offering medical annuities. However, I expect that other insurers will begin selling them soon.

Please address your financial questions to Malcolm Berko, P.O. Box 8303, Largo, FL 33775, or email him at mjberko@yahoo.com. To find out more about Malcolm Berko and read features by other Creators Syndicate writers and cartoonists, visit the Creators Syndicate website at www.creators.com.
COPYRIGHT 2017 CREATORS.COM

You May Also Like

Theater Groups in South Florida Receive Grant Funding for Shakespeare Remake

The funds will allow a modern-day generational comedy take on Shakespeare’s Hamlet to be performed in Broward and Miami-Dade counties.

Build With Us @ Suffolk’s Business Accelerator Program Honors Minority Graduates

The company is one of the largest contractors in Florida.

Editor’s Letter: Everything Still Seems Pretty Good

I don’t know about you, but I am getting tired of waiting for a recession. Yes, there are a few worrisome signs nationally, such as vacant office space and we

Kevin Gale
Local South Florida Cocktail Recipes to Craft During National Cocktail Day 

The celebration will commence on Sunday, March 24.

Other Posts

Miami Marlins Set to Kick Off Much-Awaited 2024 Season

The team will host the Pittsburgh Pirates for the home opener on March 28.

Healthcare Investor Hosts Fundraising Event for Fort Lauderdale Mayor Dean Trantalis

The evening will feature a Frank Sinatra impersonator, networking and a chance to raffle prizes from Amaira Med Spa & Surgical.

Fort Lauderdale International Film Festival Hosts Oscars Watch Party

Space is limited and advance purchase of tickets is required.

Desai Foundation Hosts Holi Celebration in Miami

The aim is to raise awareness and support for health, livelihood, and menstrual equity programs in India.

Drew Limsky

Drew Limsky

Editor-in-Chief

BIOGRAPHY

Drew Limsky joined Lifestyle Media Group in August 2020 as Editor-in-Chief of South Florida Business & Wealth. His first issue of SFBW, October 2020, heralded a reimagined structure, with new content categories and a slew of fresh visual themes. “As sort of a cross between Forbes and Robb Report, with a dash of GQ and Vogue,” Limsky says, “SFBW reflects South Florida’s increasingly sophisticated and dynamic business and cultural landscape.”

Limsky, an avid traveler, swimmer and film buff who holds a law degree and Ph.D. from New York University, likes to say, “I’m a doctor, but I can’t operate—except on your brand.” He wrote his dissertation on the nonfiction work of Joan Didion. Prior to that, Limsky received his B.A. in English, summa cum laude, from Emory University and earned his M.A. in literature at American University in connection with a Masters Scholar Award fellowship.

Limsky came to SFBW at the apex of a storied career in journalism and publishing that includes six previous lead editorial roles, including for some of the world’s best-known brands. He served as global editor-in-chief of Lexus magazine, founding editor-in-chief of custom lifestyle magazines for Cadillac and Holland America Line, and was the founding editor-in-chief of Modern Luxury Interiors South Florida. He also was the executive editor for B2B magazines for Acura and Honda Financial Services, and he served as travel editor for Conde Nast. Magazines under Limsky’s editorship have garnered more than 75 industry awards.

He has also written for many of the country’s top newspapers and magazines, including The New York Times, Washington Post, Los Angeles Times, Miami Herald, Boston Globe, USA Today, Worth, Robb Report, Afar, Time Out New York, National Geographic Traveler, Men’s Journal, Ritz-Carlton, Elite Traveler, Florida Design, Metropolis and Architectural Digest Mexico. His other clients have included Four Seasons, Acqualina Resort & Residences, Yahoo!, American Airlines, Wynn, Douglas Elliman and Corcoran. As an adjunct assistant professor, Limsky has taught journalism, film and creative writing at the City University of New York, Pace University, American University and other colleges.